Researchers found that from 2010 to 2018, the cost of brand-named epilepsy drugs rose 277% overall. Over the same period, the cost of generic drugs dropped 42%.
Researchers found that from 2010 to 2018, the cost of brand-named epilepsy drugs rose 277% overall. Over the same period, the cost of generic drugs dropped 42%.